Concepedia

Publication | Closed Access

Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study.

29

Citations

0

References

2020

Year

Abstract

In patients with RA who had an inadequate response to MTX, baricitinib was associated with significant clinical improvements as compared with placebo.